Exopharm Limited

Exopharm Limitedverified

EX1.AX

Price:

$0.011

Market Cap:

$1.93M

Exopharm Limited, a clinical-stage company, develops transformative medicines based upon extracellular vesicles (EVs) in Australia. The company's technology includes extracellular vesicle positioning system that allows specific molecules to be attached to the surface of exosomes to guide them to target tissues or cell types; leveraging oligonucleotide packing for amplified dosing, which enables specific RNA molecules to be preferentially loaded into exosomes as a therapeutic cargo; ligand-based exosome affinity purification that isolates and purifies exosomes from biofluids like blood and cell culture media. Its engineered EVs products comprise Fortrexo CoV for the treatment of SARS-CoV-2 in...[Read more]

Industry

Biotechnology

IPO Date

2018-12-17

Stock Exchange

ASX

Ticker

EX1.AX

The ROE as of November 2025 (TTM) for Exopharm Limited (EX1.AX) is -110.25%

According to Exopharm Limited’s latest financial reports and current stock price. The company's current ROE is -110.25%. This represents a change of 73.55% compared to the average of -63.53% of the last 4 quarters.

Exopharm Limited (EX1.AX) Historical ROE (quarterly & annually)

How has EX1.AX ROE performed in the past?

The mean historical ROE of Exopharm Limited over the last ten years is -83.84%. The current -110.25% ROE has changed 31.50% with respect to the historical average. Over the past ten years (40 quarters), EX1.AX's ROE was at its highest in in the December 2015 quarter at 168.49%. The ROE was at its lowest in in the June 2015 quarter at -236.00%.

Quarterly (TTM)
Annual

Average

-83.84%

Median

-44.85%

Minimum

-472.00%

Maximum

125.51%

Exopharm Limited (EX1.AX) ROE by Quarter and Year

Discovering the peaks and valleys of Exopharm Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.65%

Maximum Annual ROE = 125.51%

Minimum Annual Increase = -126.59%

Minimum Annual ROE = -472.00%

Quarterly (TTM)
Annual
YearROEChange
2023-172.77%49.70%
2022-115.41%157.35%
2021-44.85%-56.88%
2020-104.00%142.68%
2019-42.86%1.65%
2018-2.45%-103.30%
201774.24%-40.85%
2016125.51%-126.59%

Exopharm Limited (EX1.AX) Average ROE

How has EX1.AX ROE performed in the past?

The current ROE of Exopharm Limited (EX1.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-111.01%

5-year avg

-95.98%

10-year avg

-83.84%

Exopharm Limited (EX1.AX) ROE vs. Peers

How is EX1.AX’s ROE compared to its peers?

Exopharm Limited’s ROE is greater than Hexima Limited (-52.59%), less than Wellfully Limited (1.17%), greater than The Sustainable Nutrition Group Ltd (-97.19%), less than Health House International Limited (0%), less than Regeneus Ltd (455.81%), less than Jayex Technology Limited (59.66%), greater than Uscom Limited (-358.43%), greater than Total Brain Limited (-104.70%), greater than Allegra Medical Technologies Limited (-1152.11%), greater than Medibio Limited (-7.84%),

Build a custom stock screener for Exopharm Limited (EX1.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Exopharm Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Exopharm Limited (EX1.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Exopharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Exopharm Limited's ROE?

How is the ROE calculated for Exopharm Limited (EX1.AX)?

What is the highest ROE for Exopharm Limited (EX1.AX)?

What is the 3-year average ROE for Exopharm Limited (EX1.AX)?

What is the 5-year average ROE for Exopharm Limited (EX1.AX)?

How does the current ROE for Exopharm Limited (EX1.AX) compare to its historical average?